These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27977936)

  • 1. Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.
    Wagner DJ; Duan H; Chapron A; Lee RW; Wang J
    Xenobiotica; 2017 Dec; 47(12):1112-1120. PubMed ID: 27977936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.
    Hayer-Zillgen M; Brüss M; Bönisch H
    Br J Pharmacol; 2002 Jul; 136(6):829-36. PubMed ID: 12110607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.
    Haenisch B; Drescher E; Thiemer L; Xin H; Giros B; Gautron S; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1017-23. PubMed ID: 22806583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
    Bourdet DL; Pritchard JB; Thakker DR
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.
    Jouan E; Le Vee M; Denizot C; Da Violante G; Fardel O
    Fundam Clin Pharmacol; 2014 Feb; 28(1):65-77. PubMed ID: 22913740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of six protoberberine alkaloids with human organic cation transporters 1, 2 and 3.
    Li L; Sun S; Weng Y; Song F; Zhou S; Bai M; Zhou H; Zeng S; Jiang H
    Xenobiotica; 2016; 46(2):175-83. PubMed ID: 26134304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1.
    Sato T; Masuda S; Yonezawa A; Tanihara Y; Katsura T; Inui K
    Biochem Pharmacol; 2008 Oct; 76(7):894-903. PubMed ID: 18674516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of alkaloids in Coptis chinensis Franch -Tetradium ruticarpum (A. Juss.) T.G. Hartley with hOCT1 and hOCT2.
    Zhang S; Liu X; Li L; Zhang Y; Wang X; Li Y; Huang Y; Pan G
    J Ethnopharmacol; 2022 Sep; 295():115395. PubMed ID: 35597409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation.
    Yin J; Duan H; Wang J
    J Pharmacol Exp Ther; 2016 Dec; 359(3):401-410. PubMed ID: 27758931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials.
    Mulgaonkar A; Venitz J; Gründemann D; Sweet DH
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2705-11. PubMed ID: 23545524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human organic cation transporters by the alkaloids matrine and oxymatrine.
    Pan X; Wang L; Gründemann D; Sweet DH
    Fitoterapia; 2014 Jan; 92():206-10. PubMed ID: 24291757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters.
    Ming X; Ju W; Wu H; Tidwell RR; Hall JE; Thakker DR
    Drug Metab Dispos; 2009 Feb; 37(2):424-30. PubMed ID: 18971316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of
    López Quiñones AJ; Wagner DJ; Wang J
    Mol Pharmacol; 2020 Aug; 98(2):109-119. PubMed ID: 32487736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
    Kimura N; Masuda S; Katsura T; Inui K
    Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
    Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+.
    Thévenod F; Ciarimboli G; Leistner M; Wolff NA; Lee WK; Schatz I; Keller T; Al-Monajjed R; Gorboulev V; Koepsell H
    Mol Pharm; 2013 Aug; 10(8):3045-56. PubMed ID: 23763587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT).
    Müller J; Lips KS; Metzner L; Neubert RH; Koepsell H; Brandsch M
    Biochem Pharmacol; 2005 Dec; 70(12):1851-60. PubMed ID: 16263091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.
    Yin J; Duan H; Shirasaka Y; Prasad B; Wang J
    Drug Metab Dispos; 2015 Dec; 43(12):1872-81. PubMed ID: 26374172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
    Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney.
    Urakami Y; Kimura N; Okuda M; Inui K
    Pharm Res; 2004 Jun; 21(6):976-81. PubMed ID: 15212162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.